4D Molecular Therapeutics FDMT

$ 14.97 1.84%

Quarterly report 2026-Q2
added 08-13-2026

Country	USA
IPO year	2020
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	57.9 M
Market Cap^[1]	$ 867 M
EBITDA (LTM)	$ -155 M
P/E (LTM)	-6.18595
P/S (LTM)	10.177502
EPS (LTM)	-2.42

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.